Monthly News Roundup - April 2021
GSK’s Checkpoint Inhibitor Jemperli Gains Approval for Endometrial Cancer
The FDA has given accelerated approval to GSK’s Jemperli (dostarlimab-gxly), a programmed death receptor-1 (PD-1) blocking antibody used to treat adults with...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news